Atlas Trials

Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum

Clinical trial NCT06756828 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06756828
Sponsor
Saint Vincent's Hospital, Korea
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
ElderlyAlzheimer DiseaseMelatoninCognitive DeclineBiomarker with Neurodegeneration PatientsCerebellum
Start date
2025-01-15
Primary completion
2026-08-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.